8-K/A
Current Report
Arbutus Biopharma Corp Filed Acc 0001628280-17-002711
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading alexionmarch20178-ka.htm…